ArticleCureus2026
Minimally Invasive Procedures Dominate American Society of Plastic Surgeons (ASPS)-Reported Procedural Volume in 2024: A Cross-Sectional Descriptive Analysis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background National procedural volume summaries are commonly used to describe plastic surgery activity and may inform workforce planning and training exposure. However, the distribution of reported volume across practice categories and the extent of within-category concentration are not well characterized, which limits the interpretation of procedural counts. Methods A cross-sectional descriptive secondary analysis of American Society of Plastic Surgeons (ASPS)-reported procedural data for the calendar year 2024 was conducted. Procedures were grouped into three practice categories: cosmetic surgical, minimally invasive, and reconstructive. The total procedural volume was calculated for each category and expressed as a proportion of the overall ASPS activity. Within each category, procedures were ranked by 2024 volume. Concentration was assessed using the Top-5 concentration ratio (CR5), with supplementary analyses using the Top-3 concentration ratio (CR3) and the Herfindahl-Hirschman Index (HHI). Results In 2024, the total ASPS procedural volume across cosmetic surgical, minimally invasive, and reconstructive practice categories was 30,877,819 procedures. Minimally invasive procedures accounted for 28,243,407 procedures (91.5% of the total volume), compared with 1,585,878 cosmetic surgical procedures (5.1%) and 1,048,534 reconstructive procedures (3.4%). Minimally invasive volume exceeded cosmetic surgical volume by 26,657,529 procedures and reconstructive volume by 27,194,873 procedures. The five highest-volume procedures accounted for 69.4% of cosmetic surgical volume, 83.6% of minimally invasive volume, and 80.3% of reconstructive volume. Supplementary concentration metrics showed the same pattern, with CR3 values of 52.1%, 67%, and 69.9% and HHI values of 0.1212, 0.1960, and 0.1929, respectively. Conclusions The ASPS procedural volume in 2024 was dominated by minimally invasive procedures and was highly concentrated within practice categories. These findings support interpreting procedural totals alongside case mix and within-category concentration rather than relying on procedure counts alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.